Skip to content

Clinical study of CMR to evaluate cardiac structural and functional changes before and after Simultaneous pancreas and kidney transplantation

Clinical Study on the Evaluation of Changes in Cardiac and Myocardial Cell Structure and Function After Simultaneous Pancreas-Kidney Transplantation Using Cardiac Magnetic Resonance Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120868
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage Diabetic Nephropathy, Diabetes with End-stage Renal Disease

Interventions

Patients undergoing simultaneous pancreas-kidney transplantation:None

Sponsors

Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years. 2. Patients diagnosed with "end-stage diabetic nephropathy or diabetes complicated by end-stage renal disease". 3. Preoperative evaluation, surgery, perioperative management, and postoperative follow-up were conducted according to the clinical diagnosis and treatment protocols for simultaneous pancreas-kidney transplantation at our center. 4. Cardiac and myocardial cell structure and function were assessed using cardiac magnetic resonance imaging during the stable phase of post-transplantation renal and pancreatic function, as well as at the 6th and 12th months postoperatively.

Exclusion criteria

Exclusion criteria: Contraindications to CMR (surgically implanted devices such as cardiac pacemakers, cerebral aneurysm clips, cochlear implants, severe claustrophobia), as well as patients with severe cardiopulmonary dysfunction unable to tolerate CMR examination.

Design outcomes

Primary

MeasureTime frame
Left ventricular ejection fraction, LVEF;Native T1;

Secondary

MeasureTime frame
Amylase;Creatinine?;

Countries

China

Contacts

Public ContactLi Guanghui

Second Affiliated Hospital of Guangzhou Medical University

122492765@qq.com+86 20 3919 5869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026